EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Redox status of apolipoprotein E in cerebrospinal fluid: a mechanistically informative biomarker for central nervous system disorders

Yui Uematsu, Wakana Iinuma, Riho Shimizu, Hiroto Matsuura, Tsuneaki Yoshinaga, Masahide Yazaki, Kazuyoshi Yamauchi iD

Bioscience Reports · 20.05.2026 · 46 (5)

DOI: 10.1042/bsr20250388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience Reports, online erschienen am 14.05.2026. Verfasst von Yui Uematsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan. Hauptthemen laut MEDLINE: Apolipoproteins E, Central Nervous System Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shinshu Public Utility Foundation for Promotion of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apolipoprotein (apo) E is the major cholesterol carrier in the central nervous system (CNS); however, the clinical relevance of its cysteine-thiol redox status in cerebrospinal fluid (CSF) remains unclear. We investigated whether CSF apoE redox indices (redox-IDX-apoE) reflect cholesterol transport efficiency and disease-specific pathologies. We quantified reduced (red), reversibly oxidized (roxi), and irreversibly oxidized (oxi) apoE in CSF and serum using a maleimide-based band-shift assay. We analyzed relationships between redox-IDX-apoE, CSF cholesterol (TC) level, and the TC/apoE ratio (inverse transport efficiency) in patients with apoE3/E3 and identified transport determinants using isometric log-ratio (ILR) regression. Significant but only moderate correlations between CSF and serum indices suggested distinct redox behavior in the two compartments. ApoE3/E4 carriers exhibited higher oxi-apoE, reflecting reduced buffering capacity. In apoE3/E3 CSF, aging increased roxi/total and decreased red/roxi, suggesting a shift toward oxidized forms. CSF TC levels positively correlated with roxi-related indices. Conversely, the TC/apoE ratio negatively correlated with red/roxi, indicating that red-apoE supports higher efficiency. ILR analysis confirmed that maintaining the reduced monomeric state, rather than the reversibly oxidized form, was independently associated with improved transport efficiency. Diagnostic groups exhibited distinct signatures: neurodegenerative disorders showed elevated irreversible oxidation, whereas neuroimmunological and infectious conditions exhibited profiles suggestive of reversible and acute oxidation, respectively. The CSF apoE redox status links local redox balance to cholesterol handling and reflects CNS pathophysiology. Maintaining reduced cysteine-thiol appears important for functional capacity, whereas a shift toward oxidation reflects a trade-off between buffering ability and transport efficiency. These indices may serve as potential biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoproteins ECentral Nervous System DiseasesHumansOxidation-ReductionBiomarkersCholesterolFemaleMaleAgedMiddle AgedApolipoprotein E3Apolipoprotein E4

Stichwörter der Autor:innen

Alzheimer’s diseaseCysteine-thiolcholesterol transportdisulfide bondoxidative stress

Substanzen

BiomarkersCholesterolApolipoproteins EApoE protein, humanApolipoprotein E3Apolipoprotein E4

Autor:innen und Institutionen

  • Department of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan.
  • Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan.
  • Department of Neurology and Rheumatology, Shinshu University, Matsumoto, Japan.
  • Division of NeuroHealth Innovation, Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan.
  • Department of Biomedical Laboratory Sciences, School of Health Sciences, Shinshu University, Matsumoto, Japan.

ORCID-Profile: Kazuyoshi Yamauchi

Förderung

  • Shinshu Public Utility Foundation for Promotion of Medical Sciences

Zitieren

APA

Uematsu, Y., Iinuma, W., Shimizu, R., Matsuura, H., Yoshinaga, T., Yazaki, M., & Yamauchi, K. (2026). Redox status of apolipoprotein E in cerebrospinal fluid: a mechanistically informative biomarker for central nervous system disorders. Bioscience Reports, 46(5). https://doi.org/10.1042/bsr20250388

Vancouver

Uematsu Y, Iinuma W, Shimizu R, Matsuura H, Yoshinaga T, Yazaki M, et al. Redox status of apolipoprotein E in cerebrospinal fluid: a mechanistically informative biomarker for central nervous system disorders. Bioscience Reports. 2026;46(5). doi:10.1042/bsr20250388

BibTeX
@article{Uematsu2026,
  author = {Uematsu, Yui and Iinuma, Wakana and Shimizu, Riho and Matsuura, Hiroto and Yoshinaga, Tsuneaki and Yazaki, Masahide and Yamauchi, Kazuyoshi},
  title = {Redox status of apolipoprotein E in cerebrospinal fluid: a mechanistically informative biomarker for central nervous system disorders},
  journal = {Bioscience Reports},
  year = {2026},
  volume = {46},
  number = {5},
  doi = {10.1042/bsr20250388}
}
Kostenlos starten →